Arkolith/Insider Trading/ENVB/Form 4

Hagel Jillian Marie

Chief Technology OfficerEnveric Biosciences, Inc. (ENVB) · full profile →Form 4 · filed Oct 18, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
2 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 16, 2021Grant(A)82K——82K
Sep 16, 2021Grant(A)532K——532K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 16, 2021Grant(A)100K——100K
Sep 16, 2021Grant(A)1K——1K
Sep 16, 2021Grant(A)532K——532K
Sep 16, 2021Grant(A)80K——80K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-21-025638) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Enveric Biosciences, Inc.

Build

Ask your agent about ENVB insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001493152-21-025638"
Ask your agent
Use Arkolith to summarize insider buying and selling at Enveric Biosciences, Inc.
over the last 90 days and cite the filings.